Depletion of CD169+ border-associated macrophages induces Parkinson's disease-like behavior

Takuto Ohki1, Kai Kitamura2, Katsuhiro Tokutake1

  • 1Department of Hand Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Frontiers in Neuroscience
|December 22, 2025
PubMed

Insights

Loss of specific brain immune cells, CD169+ border-associated macrophages (BAMs), triggers Parkinson's disease-like behaviors without neurodegeneration. This discovery highlights a novel neuroimmune link to Parkinsonian pathology.

Area of Science:

  • Neuroimmunology
  • Neuroscience
  • Pathology

Background:

  • Parkinson's disease (PD) and Alzheimer's disease (AD) exhibit complex behavioral symptoms without apparent structural brain damage.
  • Border-associated macrophages (BAMs) at brain interfaces regulate central nervous system (CNS) function, but distinct subset roles are unclear.
  • Specific roles of BAM subsets in neurodegenerative diseases require further investigation.

Purpose of the Study:

  • To identify specific BAM subsets involved in Parkinson's disease (PD) pathology.
  • To investigate the functional role of CD169+ BAMs in the CNS.
  • To establish a novel model linking immune cell dysfunction to Parkinsonian phenotypes.

Main Methods:

  • Reanalysis of single-nucleus RNA sequencing data from postmortem PD brains.
  • Utilized CD169-DTR mice for selective ablation of CD169+ BAMs.
  • Evaluated behavioral and histological changes following BAM depletion.

Main Results:

  • A subset of CD169+ BAMs was significantly reduced in PD patients.
  • Depletion of CD169+ BAMs induced tremors, abnormal reflexes, and anxiety-like behavior.
  • Histological analysis showed reduced mitral and tufted cells in the olfactory bulb, disrupting olfactory-limbic circuitry, without dopaminergic neuron loss.

Conclusions:

  • CD169+ BAMs are crucial for neural network stability and motor function.
  • Loss of CD169+ BAMs can induce Parkinsonian phenotypes independent of dopaminergic neurodegeneration.
  • This study reveals a neuroimmune mechanism contributing to PD-like disorders.